Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Change in Cash (2021 - 2025)

Burning Rock Biotech has reported Change in Cash over the past 5 years, most recently at $2.0 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 38.42% year-over-year to $2.0 million; the TTM value through Dec 2025 reached -$2.4 million, up 90.31%, while the annual FY2025 figure was -$5.9 million, 53.93% up from the prior year.
  • Change in Cash for Q4 2025 was $2.0 million at Burning Rock Biotech, up from $1.7 million in the prior quarter.
  • Over five years, Change in Cash peaked at $29.0 million in Q1 2021 and troughed at -$76.0 million in Q4 2021.
  • A 5-year average of -$17.4 million and a median of -$13.2 million in 2023 define the central range for Change in Cash.
  • Biggest five-year swings in Change in Cash: crashed 189.48% in 2022 and later soared 208.04% in 2024.
  • Year by year, Change in Cash stood at -$76.0 million in 2021, then grew by 2.01% to -$74.5 million in 2022, then skyrocketed by 95.93% to -$3.0 million in 2023, then soared by 208.04% to $3.3 million in 2024, then crashed by 38.42% to $2.0 million in 2025.
  • Business Quant data shows Change in Cash for BNR at $2.0 million in Q4 2025, $1.7 million in Q3 2025, and -$9.4 million in Q2 2025.